Medetomidine: Clinical Recognition and Implications in the Toxic Drug Crisis
Addiction Medicine Fellow, BC Centre on Substance Use
March 24, 2026
12pm – 1pm PT
Learning Objectives:
-
Describe strategies for managing acute and subacute pain in hospitalized patients with opioid use disorder
-
Identify the clinical features and toxidrome of medetomidine exposure, including how it presents in intoxication and withdrawal and how it may differ from or overlap with opioid and other sedative exposures.
-
Explain the implications of medetomidine in the toxic drug supply, including challenges in detection, impacts on overdose management and withdrawal care, and considerations for harm reduction and clinical response in the current drug toxicity crisis.
What’s New in Addiction Medicine? is a lunch-time series featuring clinicians and researchers from BCCSU’s interdisciplinary fellowship program, who will deliver the latest research and information on novel, evidence-based addiction medicine topics.
This free series is geared towards the needs and interests of individuals operating in a healthcare or research setting, however, everyone is welcome and encouraged to attend.
In-person seminar will have complimentary lunch provided.
Register for In-Person Attendance:
Register
Register for Virtual Attendance:
Register
If you have any questions about event logistics, please contact [email protected].